UROGEN PHARMA LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.22 USD | +0.08% |
|
+3.77% | -11.87% |
| May. 14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
| May. 13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UROGEN PHARMA LTD. | Bio Therapeutic Drugs | +0.08% | +3.77% | -11.87% | +11.09% | -65.46% | 478M |  |  | |
- Stock Market
- Equities
- URGN Stock
- Charts UroGen Pharma Ltd.
- Relative Strength Chart
